
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Judge tosses 3M’s blackmail case against Porton CEO Boulter

A judge in New York tossed 3M Co.’s (NYSE:MMM) lawsuit accusing Porton Group and its CEO Harvey Boulter of a campaign of "blackmail" and "extortion" to get a $30 million payment, the latest round in a complicated case originating with 3M’s purchase of the BacLite test from Porton in 2007.
2. World Heart CFO on layoffs, future plans


A skeleton crew of 6 employees at World Heart Corp. (NSDQ:WHRT) will push ahead with the development of its MiFlow heart pump despite layoffs for 77% of their colleagues, CFO Morgan Brown told MassDevice.com this morning.
1. Is Boston Scientific in line for a private equity takeover?


Billionaire hedge fund manager David Tepper, of Appaloosa Management, bought 7.8 million shares of Boston Scientific stock during the 4th quarter, according to regulatory filings, for a stake with a market value of $41.6 million as of Dec. 31.